|
Q3 FY2026
As of Oct 2, 2026
|
Q2 FY2026
As of Jul 3, 2026
|
Q1 FY2026
As of Apr 3, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Oct 3, 2025
|
Q2 FY2025
As of Jul 4, 2025
|
Q1 FY2025
As of Apr 4, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 27, 2024
|
Q2 FY2024
As of Jun 28, 2024
|
Q1 FY2024
As of Mar 29, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 29, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jul 1, 2022
|
Q1 FY2022
As of Apr 1, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| CURRENT ASSETS: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Trade receivables, less allowance for credit losses of $21,992 and $21,765 | |||||||||||||||||||
| Inventories, net | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property, plant and equipment, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Lease assets - right of use | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Long-Term Debt, Current Maturities | |||||||||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||||||
| CURRENT LIABILITIES: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Common Stock, Shares, Issued | |||||||||||||||||||
| Equity: | |||||||||||||||||||
| 6.50% Series A Mandatory Convertible Preferred Stock, 175,000 shares issued and outstanding at October 2, 2026; no shares issued or outstanding at December 31, 2025 | |||||||||||||||||||
| Common stock - $0.001 par value - 600,000,000 shares authorized, 62,175,585 and 60,721,079 shares outstanding as of October 2, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Total ESAB Corporation equity | |||||||||||||||||||
| Noncontrolling interest | |||||||||||||||||||
| Total equity | |||||||||||||||||||
| Total liabilities and equity | |||||||||||||||||||
| Common stock, par value (in dollars per share) | |||||||||||||||||||
Loading...